Know Qian jiawanhu: Nanjing Qianjia wanhu Biotechnology Co., Ltd. is a professional R&D and operation company invested and established in China by international leading suppliers of in vitro diagnostic reagent raw materials. Headquartered in Switzerland, it is committed to introducing the world's leading in vitro diagnostic reagent technology into greater China, and engaging in the R&D, production and sales of in vitro diagnostic raw materials and reagents with reference to international standards.
The main businesses of the company include antigens, antibody raw materials, reagents and quality control products of in vitro diagnostic reagents. The company has completed the strategic layout in East China and provided professional technical solutions for customers in the in vitro diagnosis industry.
The company focuses on the research of antigen antibody raw materials, kits and quality control products such as Alzheimer's disease, neuroimmunity, tumor markers, infectious diseases, drugs, blood coagulation, myocardial markers, coronavirus, cytokines, etc., and has won the trust of many industry benchmark customers.

Group background: Headquartered in Switzerland, the group has established R&D and operation companies in Germany, Chinese Mainland and Taiwan to engage in the introduction and transformation of various technologies and products. The main business segments include the research and development of life sciences and health products and the development and supply of diagnostic reagent raw materials. At present, it occupies a very important and indispensable position in the global reagent raw material supply chain. The members of the group's management team have been engaged in relevant technical research and market operation for 30 years. At present, all product raw materials of the company have adopted the international most cutting-edge technology. The core customer base includes the top five international peer companies, related industries and drug regulatory customers, as well as drug regulatory agencies in Europe and the United States.

Nanjing qianjiawanhu Biotechnology Co., Ltd. provides customers with various high-quality reagent raw materials and relevant professional information, especially the international advanced technology in neuroimmunology, such as the antibody and antigen technology transformation of various international standard products such as Parkinson's disease and Alzheimer's disease. It always adheres to the core value of "making products and services carefully" and is committed to the corporate vision of "making medical technology serve thousands of families".